Epic Systems Corporation vs Pfizer

Side-by-side comparison of AI visibility scores, market position, and capabilities

Pfizer leads in AI visibility (93 vs 72)
Epic Systems Corporation logo

Epic Systems Corporation

LeaderHealthcare

Electronic Health Records (EHR) & Healthcare Software

Epic Systems is the dominant EHR vendor in the U.S., used by over 300 million patients' records and deployed at more than 300 health systems including most major U.S. academic medical centers; privately held; generates over $4B in annual revenue;

AI VisibilityBeta
Overall Score
B72
Category Rank
#117 of 596
AI Consensus
74%
Trend
stable
Per Platform
ChatGPT
78
Perplexity
71
Gemini
77

About

Epic Systems Corporation is a healthcare software company founded in 1979 by Judith Faulkner and headquartered in Verona, Wisconsin. The company is the dominant vendor of electronic health record (EHR) systems in the United States, with its software used to manage records for more than 300 million patients across more than 300 major health systems, hospitals, and academic medical centers. Epic's EHR platform — known as EpicCare — is an integrated, comprehensive clinical and administrative system covering patient records, order entry, scheduling, billing, pharmacy, lab results, imaging, and population health management, all within a single longitudinal patient record architecture.

Full profile
Pfizer logo

Pfizer

LeaderHealthcare Tech

Enterprise

Global biopharma with $63.6B FY2024 revenue; $43B Seagen ADC acquisition rebuilds post-COVID pipeline; patent cliff 2026-2028 for Eliquis; activist Starboard Value pushing restructuring.

AI VisibilityBeta
Overall Score
A93
Category Rank
#1 of 596
AI Consensus
80%
Trend
up
Per Platform
ChatGPT
94
Perplexity
89
Gemini
94

About

Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The company trades on NYSE (PFE) and reported $63.6 billion in total revenues for FY2024, normalizing from pandemic highs of $100 billion-plus in 2021-2022 driven by Comirnaty COVID-19 vaccine revenues with BioNTech and Paxlovid COVID antiviral sales. CEO Albert Bourla has led a strategic pivot to reset the company's long-term growth profile, anchored by the landmark $43 billion acquisition of Seagen in December 2023, adding a world-class antibody-drug conjugate (ADC) oncology pipeline including Padcev, Tukysa, Adcetris, and Tivdak.

Full profile

AI Visibility Head-to-Head

72
Overall Score
93
#117
Category Rank
#1
74
AI Consensus
80
stable
Trend
up
78
ChatGPT
94
71
Perplexity
89
77
Gemini
94
68
Claude
92
72
Grok
98

Key Details

Category
Electronic Health Records (EHR) & Healthcare Software
Enterprise
Tier
Leader
Leader
Entity Type
brand
company

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.